[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366599-105":59,"doc-detail-366599-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","genital-mycoplasma-infections-a-hidden-factor-in-cervical-cancer-progression-a-systematic-review-and-meta-analysis","Genital mycoplasma infections: a hidden factor in cervical cancer progression - A systematic review and meta-analysis","","Exploring how the genital microbiome, specifically genital mycoplasmas, may influence cervical cancer progression provides potential insight into tumorigenesis, therapeutic targets, and personalized management. This systematic review and meta-analysis evaluates associations between cervical cancer and genital mycoplasma infections, with attention to interactions involving human papillomavirus (HPV). Evidence synthesized across studies shows increased cervical cancer risk linked to genital mycoplasmas and suggests synergistic effects with HPV, supporting screening in high-risk groups.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/genital-mycoplasma-infections-a-hidden-factor-in-cervical-cancer-progression-a-systematic-review-and-meta-analysis/366599/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/genital-mycoplasma-infections-a-hidden-factor-in-cervical-cancer-progression-a-systematic-review-and-meta-analysis/366599.png","ImageObject",300,407,{"name":92,"@type":93},"Aldword","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the systematic review address?","Question",{"text":112,"@type":113},"The review assesses whether genital mycoplasma infections are associated with cervical cancer progression, and how these infections may interact with HPV-related mechanisms.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the studies selected and what data were analyzed?",{"text":117,"@type":113},"A systematic review and meta-analysis were conducted using databases through June 2024, pooling odds ratios with 95% confidence intervals from included case-control studies.",{"name":119,"@type":110,"acceptedAnswer":120},"What are the main findings about risk and specific mycoplasma species?",{"text":121,"@type":113},"Genital mycoplasmas were associated with an increased cervical cancer risk, with Ureaplasma urealyticum showing a significant association; HPV-positive co-infection with genital mycoplasmas further increased risk.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366599,1790663754,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Zidi et al. BMC Infectious Diseases (2025) 25:1120 BMC Infectious Diseases  \n[https://doi.org/10.1186/s12879-025-11309-3](https://doi.org/10.1186/s12879-025-11309-3)  \nSYSTEMATIC REVIEW Open Access  \nGenital mycoplasma infections: a hidden factor in cervical cancer progression? A systematic review and meta-analysis  \nSabrina Zidi 1*, Wassim Y. Almawi2,3, Sarra Abassi 1, Nadine Khadraoui 1, Imen Chniba 1, Salim Chibani 1, Ghada Sahraoui4,5 and Boutheina Ben Abdelmoumen Mardassi 1*  \nAbstract  \nBackground Exploring the role of the microbiome, specifically genital mycoplasmas, in cervical cancer (CC) offers insights into tumorigenesis, potential therapeutic targets and personalized treatment strategies. Although mycoplasmas are generally identified as commensals, their contributions to gynecological cancers, mainly CC, is increasingly recognized. This study investigates the association between CC and genital mycoplasma infections, highlighting the interactions with human papillomavirus (HPV) and their impact on cellular and immune mechanisms.  \nMethods We conducted a systematic review and meta-analysis of databases through June 2024. Association strength was determined using pooled odds ratios (ORs) with 95% confidence intervals (CIs) . Six case-control studies involving 319 cervical cancer patients and 447 controls were included.  \nResults Pooled results showed that genital mycoplasmas were associated with a significantly increased risk of CC (OR = 1 . 64; 95% CI 1.25–2. 14) . The species-specific analysis demonstrated that Ureaplasma urealyticum was linked with a high risk of CC (OR = 1 . 81, 95% CI 1.31–2. 51), while no significant association was seen for Ureaplasma parvum. HPV-positive subjects co-infected with genital mycoplasmas had a markedly increased risk of CC (OR = 3 . 13, 95% CI 2.04–4. 79), highlighting potential synergistic effects in tumor progression.  \nConclusion Mycoplasmas, particularly U. urealyticum, constitute co-factors in the development of CC, likely by influencing HPV persistence and immune evasion. Systemic screening coupled with targeted treatment of genital mycoplasmas in high-risk populations is thus warranted for CC prevention.  \nKeywords Cervical cancer, Genital Mycoplasmas, Human papillomavirus, Mycoplasma, Ureaplasma  \n*Correspondence: Sabrina Zidi[zidisabrina86@gmail.com](zidisabrina86@gmail.com)  \nBoutheina Ben Abdelmoumen Mardassi [boutheina. mardassi@pasteur.utm.tn](boutheina. mardassi@pasteur.utm.tn)  \n1Group of Mycoplasmas, Laboratory of Molecular Microbiology, Vaccinology, and Biotechnology Development, Pasteur Institute of Tunis, Tunis, Tunisia  \n2Department of Biological Sciences, Brock University, St. Catharines, Canada  \n3Faculty of Sciences, University of Tunis El-Manar, Tunis, Tunisia 4Research Laboratory of Precision Medicine/Personalized Medicine and Oncology Investigation, Saleh Azaiez Institute, Tunis, Tunisia  \n5Faculty of Medicine of Tunis, University of Tunis-El Manar, Tunis, Tunisia  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati]","cbCainf5csSL5zy2","https://ap.wps.com/l/cbCainf5csSL5zy2","pdf",3212639,11,"English","# Abstract\n# Introduction\n## Background and rationale\n## Mycoplasmas and immune evasion\n## Links to oncogenesis and HPV","[{\"question\":\"What question does the systematic review address?\",\"answer\":\"The review assesses whether genital mycoplasma infections are associated with cervical cancer progression, and how these infections may interact with HPV-related mechanisms.\"},{\"question\":\"How were the studies selected and what data were analyzed?\",\"answer\":\"A systematic review and meta-analysis were conducted using databases through June 2024, pooling odds ratios with 95% confidence intervals from included case-control studies.\"},{\"question\":\"What are the main findings about risk and specific mycoplasma species?\",\"answer\":\"Genital mycoplasmas were associated with an increased cervical cancer risk, with Ureaplasma urealyticum showing a significant association; HPV-positive co-infection with genital mycoplasmas further increased risk.\"}]","Genital mycoplasma infections: a hidden factor in cervical cancer progression - A systematic review and meta-analysis | PDF",1790166370,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/080bcd6f90e1561ddf33a08d34f02f05.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/24fe626ca5d6bb8a4bbfe99f974bb8c6.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2bda738c0867d1567771c5645d8871bd.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/83052ed063d7397dd2a2ff803630b21c.webp",980,1306]